Literature DB >> 3398798

How accurately does the Reflotron dry-chemistry system measure plasma total cholesterol levels when used a community-screening device.

S Phillips1, L Wyndham, J Shaw, S F Walker.   

Abstract

This study compared the measurements of total cholesterol levels by means of a Reflotron dry-chemistry system and a standard laboratory method with the Hitachi 705 analyser. Simultaneous blood samples were collected by finger-prick and by venepuncture from 80 volunteers. The ranges of total cholesterol levels were 3.38-8.45 mmol/L (Reflotron) and 3.59-8.83 mmol/L (Hitachi). The mean (+/- standard deviation [SD]) difference between the two methods was 0.22 +/- 0.30 mmol/L. All the subjects provided a second finger-prick sample of blood on the next day to assess the reproducibility of the Reflotron system. The mean (+/- SD) cholesterol levels that were obtained by the Reflotron method on Day 1 and Day 2 were 5.38 +/- 1.17 mmol/L and 5.30 +/- 1.14 mmol/L, respectively. These results did not differ significantly (mean difference, 0.079 mmol/L; standard error, 0.045 mmol/L). Provided that the operator is trained appropriately, the Reflotron system gives rapid, accurate and reproducible results.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3398798

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  9 in total

Review 1.  Systematic review of near patient test evaluations in primary care.

Authors:  B C Delaney; C J Hyde; R J McManus; S Wilson; D A Fitzmaurice; S Jowett; R Tobias; G H Thorpe; F D Hobbs
Journal:  BMJ       Date:  1999-09-25

2.  Performance of the Reflotron in Massachusetts' Model System for Blood Cholesterol Screening Program.

Authors:  S Havas; R Bishop; L Koumjian; J Reisman; S Wozenski
Journal:  Am J Public Health       Date:  1992-03       Impact factor: 9.308

3.  Reflotron measurement of blood cholesterol.

Authors:  F A Majeed
Journal:  Br J Gen Pract       Date:  1992-01       Impact factor: 5.386

4.  Quality of plasma cholesterol measurements in primary care.

Authors:  P M Broughton; D G Bullock; R Cramb
Journal:  BMJ       Date:  1989-02-04

Review 5.  Diagnostic point-of-care tests in resource-limited settings.

Authors:  Paul K Drain; Emily P Hyle; Farzad Noubary; Kenneth A Freedberg; Douglas Wilson; William R Bishai; William Rodriguez; Ingrid V Bassett
Journal:  Lancet Infect Dis       Date:  2013-12-10       Impact factor: 25.071

6.  Cardiovascular risk screening program in Australian community pharmacies.

Authors:  Gregory M Peterson; Kimbra D Fitzmaurice; Helen Kruup; Shane L Jackson; Rohan L Rasiah
Journal:  Pharm World Sci       Date:  2010-03-10

7.  Plasma cholesterol and other cardiac risk factors in adolescent girls.

Authors:  M A Bermingham; E Jones; K Steinbeck; K Brock
Journal:  Arch Dis Child       Date:  1995-11       Impact factor: 3.791

8.  Self-tests for influenza: an empirical ethics investigation.

Authors:  Benedict Rumbold; Clare Wenham; James Wilson
Journal:  BMC Med Ethics       Date:  2017-05-05       Impact factor: 2.652

9.  A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting - rationale, design and baseline characteristics.

Authors:  Caroline Laurence; Angela Gialamas; Lisa Yelland; Tanya Bubner; Philip Ryan; Kristyn Willson; Briony Glastonbury; Janice Gill; Mark Shephard; Justin Beilby
Journal:  Trials       Date:  2008-08-06       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.